LAVCA VC
  • News Feed
  • VC Data
  • Directories
  • Features
  • Tech Growth Coalition
  • LAVCA Gender Diversity
  • Engage
    • VC Council
    • VC Members
  • LAVCA
  • Member Login
  • Member Access

LAVCA VC

  • News Feed
  • VC Data
  • Directories
  • Features
  • Tech Growth Coalition
  • LAVCA Gender Diversity
  • Engage
    • VC Council
    • VC Members
  • LAVCA

Invermaster Ventures IPOs Costa Rica’s Establishment Labs on the NASDAQ

July 23, 2018
Establishment Labs IPO

Invermaster Ventures completed an Initial Public Offering of Costa Rican high-tech medical device and aesthetics company Establishment Labs Holdings.

(Press Release) Invermaster Ventures is proud to announce the completion of the Initial Public Offering of Establishment Labs Holdings Inc (NASDAQ: ESTA). Establishment Labs is a global high-tech medical device and aesthetics company that designs, develops, manufactures and markets an innovative product portfolio consisting of advanced silicone-filled breast and body shaping implants.

Establishment Labs’ common shares began trading on the Nasdaq Capital Market under the ticker symbol “ESTA” on July 19th, 2018. Today the company announced the closing of its initial public offering of about 4.3 million common shares at a price of $18 per share. The gross proceeds from the offering were approximately $76.9 million and as of today’s price of $25 per share the total market cap of ESTA is estimated in $485 million (Enterprise Value of approximately $540 million).

Invermaster, a venture capital boutique in Central America, participated in the early financing of ESTA and supported the initial efforts of its global expansion. Invermaster partners with entrepreneurs helping them achieve their most ambitious business plans and working shoulder-to-shoulder with determination and purpose. Invermaster supports early stage companies with ties to Latin America focusing in FinTech, MedTech, BioTech, Crypto Assets and Blockchain.

Invermaster Ventures IPOs Costa Rica’s Establishment Labs on the NASDAQ was last modified: July 25th, 2018 by Editor
Establishment LabsHealthtechInvermaster VenturesIPOITNasdaq
0
Facebook Twitter Google +

Categories

  • Deals
  • Exits
  • Regulatory
  • M&A
  • New Funds & Firms
  • Partnerships

Sign up for LAVCA’s bi-weekly Latin American Private Capital Update and the LatAm Venture Bulletin, produced specifically for venture investors, entrepreneurs, and technology startups in the early stage ecosystem.






Which LAVCA Newsletter would you like to receive?

Tweets

  • Nicolás Szekasy https://t.co/kMv2IUnfbA

    11-Aug-2022

    Reply Retweet Favorite
  • #LAVCAWeek2022 is taking place in person Oct. 11-14 in NYC! Speakers include: Tania Sztamfater Chocolat (… https://t.co/uNg10qSqwx

    09-Aug-2022

    Reply Retweet Favorite
  • Today's top takeaways from the #LatAmVentureBulletin: https://t.co/JY9CRvO0hW https://t.co/KUabMLOT2U

    05-Aug-2022

    Reply Retweet Favorite
  • Leading VCs and tech investors active in Brazil are invited to join LAVCA's #EncontroAnualBrasil. Program highlight… https://t.co/9vWiCTnyuh

    05-Aug-2022

    Reply Retweet Favorite
  • Registration for #LAVCAWeek2022 is now open for all qualified institutional investors LAVCA Members and non-members… https://t.co/iiv4YQSuUc

    03-Aug-2022

    Reply Retweet Favorite

Keep in touch

Twitter Linkedin Youtube

About LAVCA

 

LAVCA is the Association for Private Capital Investment in Latin America, a not-for-profit membership organization dedicated to supporting the growth of private capital in Latin America and the Caribbean through research, education, networking and advocacy.

LAVCA Office

    New York City:
    589 8th Ave, 18th Floor
    New York, NY 10018

Explore LAVCA.org

  • About LAVCA
  • Board, Team, & Advisors
  • Media
  • Contact Us
  • Membership Benefits
  • Members Only Access
  • Education and Programs
  • Research
  • Policy
  • LAVCA VC
  • Contact Us

@2020 - LAVCA. All Rights Reserved.


Back To Top